Search programmes

Therapeutic area

  • Hemostasis and bleeding disorders (45)

CONNECT

Format

Duration

Accreditation

Hemostasis medical education programmes to support HCPs in their decision making for clinical practice

Programmes in Hemostasis and bleeding disorders

Showing 1 to 6 of 45 results
Show filters filter
podcast Podcast
Hemostasis and bleeding disorders 
Thrombophilia: Clinical overview and impact on patients

Part 1 of a thrombophilia podcast series

Experts
Prof. Cedric Hermans, Prof. Sabine Eichinger
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Feb 2024

Educational programme supported by an independent medical education grant from Pentapharm.
video Video
Hemostasis and bleeding disorders 
MOVE Haemophilia 2023

Implementing international guidelines and best practices for hemophilia in clinical practice

Experts
Prof. Ana Boban, Dr Christoph Königs, Prof. Jan Astermark, Prof. Pratima Chowdary, Dr Steven Kitchen, Dr Sebastien Lobet
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Dec 2023

Educational programme supported by an independent medical education grant from Sobi.
podcast Podcast
Rare diseases Hemostasis and bleeding disorders 
Rare diseases: gene therapy and gene-modified cell therapies

Current role, potential and the example of hemophilia

Experts
Prof. Cedric Hermans, Prof. Miguel Escobar
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Dec 2023

Educational programme supported by an independent medical education grant from American Society of Gene + Cell Therapy and Pfizer.
podcast Podcast

Episode

4

of 4

episode
Hemostasis and bleeding disorders 
Perioperative thromboprophylaxis revisited

Minimising the risk of thrombosis in surgical patients

Experts
Prof. Dimitrios Tsakiris, Prof. Daniel Bolliger
  • download Downloadable
    Resources
  • clock 19 MIN
  • calendar Nov 2023

Educational programme supported by an independent medical education grant from Viatris.
podcast Podcast

Episode

3

of 4

episode
Hemostasis and bleeding disorders 
VTE: What is the optimal duration of antithrombotic treatment?

Part 3 of a 4-part series on thrombosis

Experts
Prof. Dimitrios Tsakiris, Prof. Jerzy Windyga
Endorsed by
Fundacja Trombofilia i Zakrzepica
  • download Downloadable
    Resources
  • clock 26 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Viatris.
podcast Podcast

Episode

2

of 4

episode
Hemostasis and bleeding disorders Oncology 
Cancer and Thrombosis

A podcast discussion on treating thrombosis in patients with cancer

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Sep 2023

Educational programme supported by an independent medical education grant from Viatris.

Hemostasis is a complex physiological process that entails preventing blood loss from damaged vessels. It is a dynamic balance of anti-coagulation and pro-coagulation molecules and consists of three sequential processes.

Primary hemostasis

The interaction between the damaged endothelium, von Willebrand factor (VWF), and platelets is a vital process for the development of a platelet plug at the injury site.

Secondary hemostasis

The coagulation cascade is initiated on the surfaces of injured endothelium and activated platelets, where clotting factors are being activated. This leads to the formation of a fibrin mesh which provides stability to the formed platelet plug to allow wound healing.

Tertiary hemostasis

Fibrinolysis breaks down the platelet plug that allows normal structure of the endothelium, smooth endothelial lining, and normal lumen size.

Disorders of hemostasis, or an imbalance in the blood's clotting process, can both result in either hypocoagulation (bleeding) or hypercoagulation (thromboembolic disorders). Hereditary bleeding disorders are caused by the absence or deficiency of specific clotting proteins. The most common hereditary bleeding disorders are hemophilia A, hemophilia B, von Willebrand disease and immune thrombocytopenia (ITP).

Hemostasis has now been widely studied for more than a century. Life science research has generated a very detailed picture of the molecular and cellular events that play roles in normal and pathological hemostasis. Novel medication for treatment of hemostatic disorders is still a significant area of interest, taking hemophilia treatment as an example.


Explore the latest medical education programmes in hemostasis and bleeding disorders to support your clinical decision-making.